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Background: Few medium-term or long-term reports on meniscal allograft transplantations are available. In this
study, we present the results of a survival analysis of the clinical outcomes of our first 100 procedures involving
transplantation of viable medial and lateral meniscal allografts performed in ninety-six patients.
Methods: Thirty-nine medial and sixty-one lateral meniscal allografts were evaluated after a mean of 7.2 years. Sur-
vival analysis was based on specific clinical end points, with failure of the allograft defined as moderate occasional or
persistent pain or as poor function. An additional survival analysis was performed to assess the results of the sixty-
nine procedures that involved isolated use of a viable allograft (twenty of the thirty-nine medial allograft procedures
and forty-nine of the sixty-one lateral allograft procedures) and of the thirteen viable medial meniscal allografts that
were implanted in combination with a high tibial osteotomy in patients with initial varus malalignment of the lower limb.
Results: Overall, eleven (28%) of the thirty-nine medial allografts and ten (16%) of the sixty-one lateral allografts
failed. The mean cumulative survival time (11.6 years) was identical for the medial and lateral allografts. The cumula-
tive survival rates for the medial and lateral allografts at ten years were 74.2% and 69.8%, respectively. The mean cu-
mulative survival time and the cumulative survival rate for the medial allografts used in combination with a high tibial
osteotomy were 13.0 years and 83.3% at ten years, respectively.
Conclusions: Transplantation of a viable meniscal allograft can significantly relieve pain and improve function of the
knee joint. Survival analysis showed that this beneficial effect remained in approximately 70% of the patients at ten
years. This study identified the need for a prospective study comparing patients with similar symptoms and clinical
findings treated with and without a meniscal allograft and followed for a longer period with use of clinical evaluation as
well as more objective documentation tools regarding the actual fate of the allograft itself and the articular cartilage.
Level of Evidence: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.
he meniscus plays an important role in the complex
biomechanics of the knee joint. It has functions in load
bearing, load transmission, shock absorption, joint
stability, joint lubrication, and joint congruity. Removal of
this important anatomical structure eventually leads to degen-
erative changes of the articular cartilage1-3. Therefore, meniscal
tissue should be preserved whenever possible. When the me-
niscus has been completely lost, transplantation of a meniscal
allograft has been a therapeutic option with favorable results,
in terms of pain reduction and functional improvement, in
the medium and long term4-7. These improvements are pre-
sumably due to an increase in contact area and thus a decrease
in contact peak stress compared with a meniscectomized
knee8-11. While decreases in contact stresses can result in pain
relief and improved function, there is no reasonable proof that
delayed meniscal transplantation prevents or slows cartilage
degeneration in either compartment6,12.
One way to determine the clinical effectiveness of this
investigational procedure is to analyze the duration of survival
of the allograft, especially when the study involves patients
with different durations of follow-up. In this study, we present
a survival analysis carried out at a minimum of two years after
our first 100 procedures involving transplantation of a viable
meniscal allograft.
Materials and Methods
Patients
he indication for transplantation of a viable meniscal al-
lograft was moderate-to-severe pain in a younger patient
who had undergone a previous total meniscectomy, was not
old enough to be considered for a knee joint replacement, and
had good alignment of the lower limb and a stable joint.
When there was axial malalignment of the lower limb or insta-
bility of the knee joint, a corrective osteotomy or stabilization
T
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procedure was performed at the time of the transplantation.
One hundred and five meniscal allografts were trans-
planted in 101 patients between 1989 and 2001. Two patients
received a lateral meniscal allograft bilaterally, and two pa-
tients received medial and lateral meniscal allografts in the
same knee. All operations were performed at different points
of time.
The mean age (and standard deviation) at the time of
the transplantation was 35.0 ± 6.7 years (range, sixteen to fifty
years). Four meniscal allografts were transplanted in four pa-
tients who lived outside of the country and could not be con-
tacted after the operation for follow-up evaluation. One
patient was lost to follow-up immediately after the transplan-
tation procedure. This resulted in 100 meniscal allografts be-
ing available for the survival analysis, with a mean duration of
follow-up of 7.2 ± 3.6 years (range, 0.5 to 14.5 years) and a
minimum duration of two years (or until failure). The follow-
up rate was 95.2%.
Thirty-nine medial allografts and sixty-one lateral al-
lografts were implanted into seventy men and twenty-six
women.
Postoperative lower-limb alignment was assessed in all
patients on weight-bearing roentgenograms by measuring the
anatomical femorotibial axis (Table I and Appendix). These
measurements were performed in duplicate by a single ob-
server with a one-month interval between observations (intra-
class correlation coefficient = 0.851, p < 0.001, Spearman rho
test). The roentgenograms were made at the time that the os-
teotomy site was noted to be healed or within a six-month pe-
riod after the surgery.
The status of the articular cartilage was evaluated at the
time of transplantation and at the time of failure with use of a
modification of the Outerbridge13 grading system. For exam-
ple, a lesion that was graded between III and IV was recorded
in our file as 3/4 and was given a value of 3.5 (Table I and Ap-
pendix). Also, grade V, indicating bone-on-bone contact, was
added to the Outerbridge system.
Surgical Technique
All patients underwent transplantation of a viable meniscal al-
lograft. The allograft was harvested within twenty-four hours
post mortem under strictly aseptic conditions in the operating
theater. Donor tissues were obtained from the Ghent Univer-
sity Hospital Tissue Bank. The donors had died from injuries
or a disease of short duration, with the majority dying as a re-
sult of a cerebrovascular incident or an automobile accident. A
maximum age of forty-five years was set for the donors. None
had received corticosteroids or cytostatic drugs. The allograft
was maintained in culture for two weeks in Dulbecco Modi-
fied Eagle Medium (DMEM; Gibco Invitrogen, Merelbeke,
Belgium) supplemented with 20% autologous serum prior to
transplantation. Previous studies have demonstrated that me-
niscal cells remain viable and continue to synthesize their ex-
tracellular matrix molecules in this culture system14. During
TABLE I Femorotibial Alignment and Preoperative Cartilage Status According to the Outerbridge Classification13 in the 
Allograft Subgroups*
Femorotibial Alignment (deg) Preop. Cartilage Grade 
Medial meniscal allografts 5.3 ± 2.7 2.6 ± 0.8
Medial meniscal allografts and high tibial osteotomy 7.1† ± 2.8 2.9‡ ± 0.8
Isolated medial meniscal allografts 4.3† ± 2.3 2.4‡ ± 0.7
Lateral meniscal allografts 6.1 ± 2.5 2.5 ± 1
Isolated lateral meniscal allografts 6.0 ± 2.2 2.4 ± 1
*The values are given as the mean and standard deviation. †Femorotibial axial alignment differed significantly between the medial meniscal
allografts transplanted in combination with a high tibial osteotomy and the isolated medial meniscal allografts (p = 0.006, Mann-Whitney U
test). ‡The preoperative cartilage grade according to Outerbridge13 differed significantly between the medial meniscal allografts transplanted
in combination with a high tibial osteotomy and the isolated medial meniscal allografts (p = 0.062, Mann-Whitney U test).
TABLE II Types of Concomitant Surgery ➤
Medial and Lateral 
Meniscal Allografts 
in Same Knee
High Tibial Osteotomy 
for Varus Malalignment 
of Lower Limb
Femoral Varus Osteotomy 
for Valgus Malalignment 
of Lower Limb
No. % No. % No. %
Medial meniscal allografts 2 5 13 33 0 0
Lateral meniscal allografts 2 3 2 3 2 3
Total 4* 15 2
*As two patients received a medial and lateral meniscal allograft in the same knee joint, there was a total of four allografts.
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the culture period, there was ample time to screen the donors
for transmissible diseases.
All patients were operated on by the senior surgeon
(R.V.). Access to the knee joint was achieved by a lateral or
medial parapatellar arthrotomy. The insertion of the lateral
collateral ligament and popliteus tendon or the medial collat-
eral ligament was detached with an osteotomy on the femoral
side15. The osteotomy fragment was later restored by screw fix-
ation or stapling. The meniscal remnant was excised, leaving
only a bleeding meniscal rim. The meniscal rim deserves sur-
gical attention, as it serves as a strong envelope encapsulating
the medial or lateral compartment of the knee. The rim
should not be resected or transected during the operation, as
doing so leads to a breach in the envelope. The viable meniscal
allograft was then securely sutured to this rim with use of
horizontal polydioxanone surgical sutures (PDS II; Ethicon,
Somerville, New Jersey) every 3 mm in an all-inside fashion.
Bone-block fixation to the tibial plateau was not used to aug-
ment the meniscal fixation. Instead, the anterior and posterior
horns of the transplanted meniscus were sutured to the rem-
nant native horns on the tibia. This procedure has been de-
scribed in detail elsewhere15.
Postoperative rehabilitation consisted of three weeks of
non-weight-bearing with mobilization of the knee, within
pain limits, with limitation of flexion to 60°. After three weeks,
the patients were allowed to flex the knee to 90° and to start
partial weight-bearing. At six weeks, all patients were allowed
to walk with one crutch.
Concomitant Procedures
Concomitant surgical procedures, judged to be essential in a
few patients, included a high tibial osteotomy, femoral varus
osteotomy, anterior cruciate ligament repair, osteochondral
plug transfer, and microfracture (Table II). At the time of the
meniscal allografting, a high tibial valgus osteotomy was per-
formed in association with thirteen of the thirty-nine medial
allograft transplantations and two of the sixty-one lateral al-
lograft procedures (Table II). The indication for a concomi-
tant high tibial osteotomy in the patients treated with a medial
transplant was varus malalignment of the lower limb. A high
tibial osteotomy was performed in the two patients with a lat-
eral allograft to ensure decompression of the medial compart-
ment because of degeneration of the articular cartilage in both
the medial and the lateral compartment. It was thought that
shifting the mechanical axis toward the lateral compartment
could decompress the degenerated medial compartment while
the lateral compartment was protected by the lateral allograft.
This procedure was performed only twice, in the early 1990s.
Two lateral meniscal allograft transplantations were per-
formed in association with a femoral varus osteotomy to cor-
rect valgus malalignment.
The anterior cruciate ligament was reconstructed at the
time of three of the medial allograft procedures and none of
the lateral allograft procedures (Table II). The reconstruction
was performed with an intra-articular double-loop tibialis
posterior tendon allograft with use of a previously described
technique16. Thus, the population that we analyzed consisted
of patients with stable knees or with knees that had been stabi-
lized prior to meniscal allografting.
In most cases, the cartilage degeneration seen at the time
of the transplantation was limited to Outerbridge grade-II or
beginning grade-III changes (Table I and Appendix)13. Border-
line indications for meniscal allograft transplantation⎯i.e.,
focal grade-IV degenerative changes of the cartilage⎯were
treated with concomitant cartilage surgery, such as the autolo-
gous osteochondral plug transfer (OATS; Arthrex, Naples, Flor-
ida) (four of the sixty-one lateral allograft procedures and none
of the medial allograft procedures) or the microfracture tech-
nique (Osteoprep; Linvatec, Largo, Florida) (one of the thirty-
nine medial allograft procedures and two of the sixty-one lateral
allograft procedures) (Table II). All of these patients were oper-
ated on after 1998. Prior to that date, no specific treatment for
this type of cartilage lesion was performed.
Two patients underwent transplantation of both a me-
dial and a lateral meniscal allograft in the same knee joint, as
stated earlier.
Overall, nineteen (49%) of the thirty-nine medial allo-
graft transplantations and only twelve (20%) of the sixty-one
lateral allograft transplantations were associated with another
procedure in the index knee joint.
Clinical Evaluation of the Knee Joint
Since at present there is no specific system for scoring the results
of meniscal surgery, a modification of the Hospital for Special
Surgery (HSS) scoring system was used to prospectively evalu-
ate the function of the involved knee joint and the meniscal
TABLE II (continued)
Anterior Cruciate 
Ligament 
Reconstruction
Osteochondral 
Plug Transfer Microfracture
Isolated Allograft 
Procedures Total
No. % No. % No. % No. % No. %
3 8 0 0 1 3 20 51 39 100
0 0 4 7 2 3 49 80 61 100
3 4 3 69 100
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allograft17. This system is used to evaluate pain, function, range
of motion, flexion deformity, and instability of the involved
knee (see Appendix). Therefore, it is an indicator of overall knee
function17. This rating system has been used to determine knee
function in previous reviews of the results of meniscal allograft-
ing procedures and of fresh osteochondral allograft procedures
in combination with meniscal allografting15,18,19.
Since meniscal allografting specifically relieves pain and
improves function, the pain score and functional score of the
modified HSS system were used for the evaluation of the clini-
cal outcome and for the survival analysis4-7. The involved knee
joint was evaluated by experienced examiners preoperatively
and on a yearly basis postoperatively.
Statistical comparison between the preoperative pain
and function scores and the scores at the time of the latest
follow-up or at the time of failure was performed with use of
the nonparametric Wilcoxon signed-rank test, since the post-
operative score distribution was determined to be non-normal
according to the Kolmogorov-Smirnov and Shapiro-Wilk tests
(p < 0.05). Accordingly, the median scores and the 25th and
75th percentiles along with the mean scores and the standard
deviations are presented for all subgroups. The level of signifi-
cance was set at p < 0.05.
Clinical Kaplan-Meier Survival Analysis
Survival analysis was based on specific clinical end points. A
failure of the allograft was defined as moderate or severe occa-
sional or persistent pain or as poor knee function. A modified
HSS subscore for pain of <30 points indicates moderate occa-
sional or persistent pain. A modified HSS function score of
<80 points was arbitrarily chosen to define poor function.
Second-look arthroscopy was performed in cases of fail-
ure or for investigational purposes. A number of patients
agreed to undergo investigational follow-up arthroscopy of
the knee joint at the time of operative removal of a fixation
screw or staple or another procedure not related to the knee
joint. The indication for removal of the device was frequent ir-
ritation of the soft tissues around it. Data from these investiga-
tional follow-up arthroscopic procedures were used for a
separate analysis20. At the time of the second-look arthroscopy,
the integrity of the meniscal allograft and its capsular attach-
ment as well as the appearance of the articular cartilage sur-
face was evaluated. A graft that had failed mechanically and
had resulted in a pain score of <30 points and/or a function
score of <80 points was characterized either by severe degen-
eration of the allograft or by allograft-capsular detachment
noted at the time of the second-look arthroscopy. Prominent
degenerative changes in the articular cartilage were consid-
ered to be the consequence of a malfunctioning meniscal al-
lograft, even if the allograft itself showed limited or no signs
of degeneration.
In the case of mechanical failure due to major degenera-
tion and/or tearing, the meniscal allograft was partially re-
sected with use of standard procedures. In the case of
mechanical failure due to allograft-capsular detachment, su-
tures were placed according to a standard protocol21.
Some knees were converted to a total or unicompart-
mental knee arthroplasty. All such knees were considered to be
failures in the survival study. The date of failure was consid-
ered to be the date at which the modified HSS pain or func-
tion score fell below the threshold.
Postoperative magnetic resonance imaging was per-
formed in a subset of patients for a separate analysis22. Al-
though magnetic resonance imaging has an established role in
the diagnosis of meniscal pathology, its value in the postoper-
ative assessment of meniscal allografts is less clear. The corre-
TABLE III Preoperative and Postoperative* Pain Scores in the Allograft Subgroups
Pain Score (Max., 50 Points)
P Value
Mean 
Duration of 
Follow-up (yr)
Preoperative Postoperative
Median 
25th-75th 
Percentile Mean
Standard 
Deviation Median 
25th-75th 
Percentile Mean
Standard 
Deviation
Medial meniscal 
allografts
10 10-20 11.9 3.9 40 30-45 34.2 17.2 0.000 8.5
Medial meniscal 
allografts and high 
tibial osteotomy
10 10-20 14.2 10.0 45 30-50 37.7 16.2 0.008 10.1
Isolated medial 
meniscal allografts
10 10-20 11.6 7.7 40 15-50 33.5 18.6 0.001 8.2
Lateral meniscal 
allografts
10 10-20 14.8 9.3 45 40-50 42.7 10.3 0.000 6.2
Isolated lateral 
meniscal allografts
10 10-20 15.3 9.4 45 40-50 42.7 10.1 0.000 6.3
Overall 10 10-20 13.7 9.0 45 40-50 39.4 13.9 0.000 7.2
*Postoperative refers to the time of the latest follow-up or the time of failure. A significant improvement in the postoperative score was ob-
served in all subgroups.
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lation between the findings of magnetic resonance imaging
and the clinical outcome has been reported to be poor22,23.
Hence, magnetic resonance imaging was not used to define
clinical failure.
Survivorship analysis was performed for the medial and
lateral meniscal allografts separately. Since a large number of
these allograft procedures were performed with a concomitant
procedure, additional survival analyses were performed for
the isolated allograft procedures and for the allograft proce-
dures combined with high tibial osteotomy.
Two patients died, of causes not related to the allograft
transplantation, during the follow-up period. The most recent
modified HSS scores for these two patients were used for the
analysis. Since these scores were higher than the threshold, the
data were included in the survival analysis and the allografts
were not considered to be failures.
Kaplan-Meier survivorship analysis was performed with
use of SPSS 11.0 software for Windows XP (SPSS, Chicago, Il-
linois) and was based on the end points stated earlier. The
analysis examined the distribution of the times between the
meniscal allograft transplantation and failure. However, these
data included some censored cases⎯i.e., cases for which the
second event (failure) was not recorded because the allograft
had not failed by the end of the study. The Kaplan-Meier pro-
cedure was a method of estimating time-to-event models in
the presence of censored cases.
The study protocol was approved by the ethics commit-
tee of Ghent University Hospital, and informed consent was
obtained from each patient enrolled in the study.
Failure Analysis
To test possible predictors of clinical failure, a comparison of
the mean values for the initial status of the cartilage, femorotib-
ial alignment, preoperative pain score, and preoperative func-
tion score between the patients who had a failure and those who
did not was performed in each subgroup with use of the Mann-
Whitney test. The level of significance was set at p < 0.05.
Progression of degeneration of the articular cartilage at
the time of failure was measured by subtracting the initial
Outerbridge13 grade from the grade at the time of the failure.
The status of the meniscal allograft was considered to be nor-
mal (0 points) at the time of transplantation, and it was scored
as normal (0 points), having minor degeneration (1 point), or
having severe degeneration (2 points) at the time of failure.
Possible correlations between these two parameters were in-
vestigated with use of the nonparametric two-tailed Spearman
rho correlation.
Results
Clinical Outcome
he modified HSS pain and function scores improved sig-
nificantly between the preoperative and the latest follow-
up visits in the series as a whole as well as in all investigated
subgroups. The overall median and mean pain scores (maxi-
mum, 50 points) improved from 10 and 13.7 points preopera-
tively to 45 and 39.4 points at the time of final follow-up. The
overall median and mean function scores (maximum, 100
points) improved from 60 and 60.1 points preoperatively to
100 and 88.6 points at the time of final follow-up. The pain
and function scores for the specific subgroups are presented in
Tables III and IV, respectively.
Kaplan-Meier Survival Analysis
According to the clinical end-point criteria for failure, twenty-
one allografts (eleven medial and ten lateral) failed in eighteen
patients, including two who had a lateral transplant bilaterally
T
TABLE IV Preoperative and Postoperative* Function Scores in the Allograft Subgroups
Function Score (Max., 100 Points)
P Value
Mean 
Duration of 
Follow-up (yr)
Preoperative Postoperative
Median
25th-75th 
Percentile Mean
Standard 
Deviation Median 
25th-75th 
Percentile Mean
Standard 
Deviation
Medial meniscal 
allografts
60 50-75 58.6 23.6 100 80-100 83.7 25.14 0.000 8.5
Medial meniscal 
allografts and high 
tibial osteotomy
60 50-80 62.5 12.1 100 80-100 86.2 22.3 0.032 10.1
Isolated medial 
meniscal allografts
65 40-75 58.7 27.0 100 80-100 83.7 26.3 0.014 8.2
Lateral meniscal 
allografts
60 50-70 61.1 18.4 100 90-100 91.64 17.4 0.000 6.2
Isolated lateral 
meniscal allografts
60 50-75 61.5 19.5 100 90-100 92.6 15.9 0.000 6.3
Overall 60 50-70 60.1 20.5 100 90-100 88.6 21.0 0.000 7.2
*Postoperative refers to the time of the latest follow-up or the time of failure. A significant improvement in the postoperative score was ob-
served in all subgroups.
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and one who had unilateral medial and lateral transplants.
Two patients with a failure of a medial allograft had under-
gone a high tibial osteotomy and one, an anterior cruciate re-
pair. None of the patients with a failure of a lateral allograft
had undergone an osteotomy, an anterior cruciate repair, an
osteochondral plug transfer, or a microfracture at the time of
transplantation or later.
Overall, eleven (28%) of the thirty-nine medial al-
lografts failed, at a mean (and standard deviation) of 6.0 ± 3.8
years (range, 1.2 to 13.4 years) postoperatively, and ten (16%)
of the sixty-one lateral allografts failed, at a mean of 4.8 ± 2.8
years (range, 0.5 to 9.7 years) postoperatively.
On the basis of these results, a Kaplan-Meier survivorship
plot was drawn for the lateral and medial allografts (Fig. 1-A).
The mean cumulative survival time for the medial meniscal al-
lografts was 11.6 years (standard error, 0.8 year; 95% confidence
interval, 10.1 to 13.1 years). The mean survival time for the lat-
eral meniscal allografts was 11.6 years (standard error, 0.7 year;
95% confidence interval, 10.3 to 12.9 years) (Table V).
The cumulative survival rate for the medial allografts
was 86.2% (standard deviation, 5.7%) at five years, 74.2%
(standard deviation, 7.4%) at ten years, and 52.8% (standard
deviation, 14.4%) at 14.5 years. The cumulative survival rates
for the lateral transplants at five, ten, and fourteen years were
90.2% (standard deviation, 4.2%), 69.8% (standard deviation,
9.7%), and 69.8% (standard deviation, 9.7%), respectively.
The survival plots for the medial and lateral allografts did not
differ significantly (p = 0.733, log-rank test).
We performed an additional survival analysis of the sixty-
nine isolated allograft procedures (twenty of the thirty-nine
medial allograft procedures and forty-nine of the sixty-one lat-
eral allograft procedures). The Kaplan-Meier plot is shown in
Figure 1-B. Overall, seven (35%) of the twenty isolated medial
allografts and nine (18%) of the forty-nine isolated lateral al-
lografts failed at a mean of 6.8 years (standard deviation, 4.6
years; range, 1.2 to 12.2 years) and 4.8 years (standard devia-
tion, 2.9 years; range, 0.5 to 9.7 years), respectively. The mean
cumulative survival time for the isolated medial meniscal al-
lografts was 10.7 years (standard error, 1.0 year; 95% confidence
interval, 8.8 to 12.6 years) (Table V). The mean survival time for
the isolated lateral meniscal allografts was 11.4 years (standard
error, 0.8 year; 95% confidence interval, 9.9 to 12.85 years). The
cumulative survival rate for the isolated medial allografts was
84.1% (standard deviation, 8.4%) at five years, 72.4% (standard
deviation, 10.6%) at ten years, and 27.2% (standard deviation,
21.1%) at 13.4 years. The cumulative survival rates for the iso-
lated lateral transplants were 90.9% (standard deviation, 4.4%),
66.8% (standard deviation, 11.3%), and 66.8% (standard devia-
tion, 11.3%) at five, ten, and fourteen years, respectively. The
TABLE V Failures, Survival Time, and Mean Cumulative Survival Rate in the Allograft Subgroups
Cases Failures
Survival 
Time*
Cumulative Survival Rate†
No. % No. % 5 Yr 10 Yr 14 Yr
Medial meniscal allografts 39 100 11/39 28 11.6 ± 0.8 86.2 ± 5.7 74.2 ± 7.4 52.8 ± 14.4
Medial meniscal allografts 
and high tibial osteotomy
13/39 33 2/13 15 13.0 ± 1.0 100.0 ± 0.0 83.3 ± 10.7 83.3 ± 10.7
Isolated medial meniscal 
allografts
20/39 51 7/20 35 10.7 ± 1.0 84.1 ± 8.4 72.4 ± 10.6 27.2 ± 21.1
Lateral meniscal allografts 61 100 10/61 16 11.6 ± 0.7 90.2 ± 4.2 69.8 ± 9.7 69.8 ± 9.7
Isolated lateral meniscal 
allografts
49/61 80 9/49 18 11.4 ± 0.8 90.9 ± 4.4 66.8 ± 11.3 66.8 ± 11.3
*The values are given as the mean and standard error. †The values are given as the percentage and standard deviation.
Fig. 1-A
Figs. 1-A, 1-B, and 1-C Kaplan-Meier cumulative survival plots. Ab-
scissa = years of follow-up, and ordinate = percentage of cumulative 
survival. Cumulative survival rates (and standard error) at the five, ten, 
and fourteen-year time-points for the patient subgroups are given in 
Table V. Fig. 1-A Survival of the total group of medial meniscal al-
lografts (MMT) compared with that of the total group of lateral meniscal 
allografts (LMT).
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survival plots for the isolated medial and lateral allograft proce-
dures did not differ significantly from one another (p = 0.680,
log-rank test).
Since a large number of medial transplants (thirteen)
were combined with a high tibial osteotomy, a comparison was
made between the grafting procedures performed with a high
tibial osteotomy and those done without a high tibial osteot-
omy. Only two of the thirteen medial grafting procedures per-
formed with a high tibial osteotomy failed compared with seven
of the twenty that were done as isolated transplants. The sur-
vival plot is shown in Figure 1-C. The mean cumulative survival
time for the medial allografts associated with a high tibial os-
teotomy was 13.0 years (standard error, 1.0 year; 95% confi-
dence interval, 11.1 to 15.0 years), and the survival rate was
83.3% (standard deviation, 10.7%) at ten years (Table V). The
difference between the medial grafting procedures performed
with and without a high tibial osteotomy was not significant (p =
0.156, log-rank test) as a result of the small number of cases.
Failure Analysis
No significant difference concerning the initial cartilage sta-
tus, femorotibial alignment, or preoperative function was ob-
served between the knees in which the graft failed and those in
which it did not fail in any subgroup. The preoperative pain
score, however, differed significantly between the failures and
the non-failures in both the total medial allograft subgroup
and the isolated medial allograft subgroup (p = 0.008 and
0.013, respectively). This difference was not observed in the
other subgroups (Table VI).
Of the twenty-one failures, seventeen (81%; nine medial
allografts and eight lateral allografts) were characterized by pro-
gression of articular cartilage degeneration and twenty (95%;
eleven medial allografts and nine lateral allografts) showed pro-
gression of allograft degeneration at the time of failure. Eight of
the failed allografts showed severe degeneration and twelve
showed only minor degenerative changes at arthroscopy. One of
the knees, with a failure due to capsular detachment, had a nor-
mal meniscal allograft. The degenerative changes in the articu-
lar cartilage were classified as Outerbridge13 grade V in nine
cases, grade IV in two, grade III in six, grade II/III in two, and
grade II in two (see Appendix). Of the twenty-one knees with a
failure, nine (six with a medial allograft, two with a lateral al-
lograft, and one with unilateral medial and lateral allografts)
were converted to a total or unicompartmental knee prosthesis
at a mean of 6.3 years (standard deviation, 3.6 years; range, one
to twelve years) because of progression of cartilaginous degen-
eration (grade V in nine cases and grade III in one) and/or me-
niscal degeneration (severe in five cases and minor in five). Two
allografts (one medial and one lateral) had to be reattached be-
cause of meniscocapsular detachment. Both healed uneventfully.
Higher grades of articular cartilage degeneration at the
time of failure were associated with significantly more severe de-
generation of the meniscal allograft (Spearman rho correlation
coefficient, 0.509; p = 0.018, indicating a moderate correlation).
Detailed scatterplots depicting these degenerative changes
of the articular cartilage and meniscal allografts are shown in
the Appendix.
Discussion
t is difficult to compare previously published results with our
results because of large differences in meniscal preservationI
Fig. 1-B
Survival of the isolated medial meniscal allografts (Isol.MMT) com-
pared with that of the isolated lateral meniscal allografts (Isol.LMT).
Fig. 1-C
Survival of the medial meniscal allografts transplanted in combination 
with a high tibial osteotomy (MMT+HTO) compared with that of the iso-
lated medial meniscal allografts (Isol.MMT). 
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techniques, types of surgical fixation, concomitant procedures,
clinical scoring systems, and, very importantly, follow-up times24,25.
Our study showed that transplantation of medial and lat-
eral meniscal allografts significantly reduces pain and improves
function of the involved knee joint as measured with the modi-
fied HSS score. Our findings substantiate previously published
reports on the clinical success of this procedure4,7,24-26.
Since the rate of clinical success of any surgical procedure
is strongly dependent on the duration of follow-up, we per-
formed a Kaplan-Meier survival analysis. In this analysis, it is
assumed that all patients had the operation simultaneously. We
compared survival times and rates among different groups of
patients treated with transplantation of a viable meniscal al-
lograft. The mean survival times and cumulative survival rates
were comparable between the lateral and medial allografts. In
contrast, van Arkel and de Boer noted a considerable difference
between these two types of grafts in their series, in which the
mean survival times were 9.25 and 5.75 years for the lateral and
medial allografts, respectively, and the survival rates were 76.54%
at ten years for the lateral allografts and 50.6% at nine years for
the medial allografts27. In their study, the Lysholm score and
arthroscopic findings were used to define clinical failures of
cryopreserved allografts fixed with a comparable soft-tissue
technique. The greater survival time and rate for the medial al-
lografts in our series compared with those in other reports27 can
be attributed to the lower number of anterior cruciate-deficient
knees in our series. Increased anterior tibial translation due to
deficiency of the anterior cruciate ligament is known to induce
higher stress on the medial meniscus and therefore can induce
secondary graft detachment and failure27.
We performed a survival analysis on twenty cases of iso-
lated medial allograft transplantation and forty-nine cases of
isolated lateral allograft transplantation. Again, survival times
and rates were observed to be comparable between the two
groups.
The failure rates and survival times differed between
the isolated medial meniscal allografts transplanted into a well-
aligned lower limb and the medial meniscal allografts combined
with a high tibial osteotomy to correct varus malalignment.
Combining the medial allograft procedure with a high tibial
osteotomy appears to result in longer allograft survival and
fewer failures. We hypothesized that the shift of the mechani-
cal axis toward the lateral compartment unloads the medial
meniscal allograft and thus makes it less prone to failure, even
though the initial cartilage degeneration at the time of trans-
plantation was more severe in the group treated with the os-
teotomy. However, it cannot be concluded that a high tibial
osteotomy should be performed in association with medial
meniscal transplantation in a limb with normal axial align-
ment. Rather, it can be concluded that transplantation of a
medial meniscal allograft in a varus-aligned knee should be
combined with a high tibial osteotomy since varus malalign-
ment is an absolute contraindication to transplantation of a
medial meniscal allograft5,18,25-28.
Overall, twenty-one of the 100 viable allografts in our
study failed at a mean of 5.4 ± 3.3 years. The failure rate was
28% for the medial allografts, at a mean of 6.0 ± 8.8 years,
compared with 16% for the lateral allografts, at a mean of 4.8
± 2.8 years. The fact that the failure rate for the medial al-
lografts was higher than that for the lateral allografts can be
explained by the longer mean duration of follow-up for the
former group. The follow-up was longer because the number
of indications for medial allograft transplantation at our insti-
tution was higher in the early years of this study. The number
of patients with a total meniscectomy in the medial compart-
ment and associated pain has decreased since then. However,
because the lateral meniscus plays a greater role in stress pro-
tection, a lateral meniscectomy can result in a painful knee
more rapidly, leading to the higher number of knees treated
with transplantation of a lateral meniscal allograft with a
shorter mean follow-up time2.
The overall rate of failure of the viable meniscal allografts
in our study is consistent with previously published medium-
term and long-term data on deep-frozen and cryopreserved al-
lografts fixed with a bone-plug or soft-tissue technique4,5,7. Our
overall failure rate of 21% is, however, clearly lower than the
failure rates of deep-frozen, irradiated allografts (failure rate,
44%) or lyophilized allografts4,28. Both preservation techniques
are known to render the graft acellular and may adversely affect
the material properties of the graft29-32. Cultured menisci have
been shown to remain viable and to continue to produce extra-
cellular matrix compounds⎯hence, the term “viable meniscal
allograft.”14 After a two-week culture period, the meniscus is
transplanted into the recipient knee. The proportion of cells
TABLE VI Comparison of Possible Predictors of Clinical Failure in the Allograft Subgroups ➤
Femorotibial Alignment (deg) Preop. Cartilage Grade13
Non-Failures* Failures* P Value Non-Failures* Failures* P Value
Medial meniscal allografts 5.3 ± 2.8 5.3 ± 2.6 0.96 2.6 ± 0.9 2.6 ± 0.7 0.86
Medial meniscal allografts and high 
tibial osteotomy
6.7 ± 2.9 9.0 ± 1.4 0.15 2.9 ± 0.9 3.2 ± 0.4 0.64
Isolated medial meniscal allografts 4.4 ± 2.6 4.0 ± 1.7 0.64 2.3 ± 0.8 2.4 ± 0.8 0.76
Lateral meniscal allografts 6.1 ± 2.4 5.8 ± 2.7 0.65 2.5 ± 1.0 2.5 ± 0.9 0.78
Isolated lateral meniscal allografts 6.0 ± 1.0 5.6 ± 0.9 0.50 2.4 ± 1.0 2.4 ± 0.9 0.91
*The values are given as the mean and standard deviation.
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that survive and how long they survive in vivo are unknown.
Jackson et al. used DNA probe analysis in a goat model and
found that all donor cells were rapidly replaced by host cells
over a period of four weeks33. However, a previous study per-
formed in our department demonstrated the presence of do-
nor DNA in the viable human meniscal allograft for as long as
sixty-four months after transplantation, indicating that donor
cells remain viable for a longer period and the replacement
process by host cells is probably slower in the human model20.
The biomechanical function of the meniscal allograft depends
not only on the quality of the surgical fixation technique, but
also on the phenotype of the cell population of the allograft. It
is not known if recipient meniscus-invading cells, probably de-
rived from the synovial lining, have the same capacity to pro-
duce extracellular matrix as have native meniscus cells8,34. It was
hypothesized at the start of this study that the use of viable me-
niscal allografts would be more beneficial than the use of acel-
lular grafts (deep-frozen, lyophilized, or cryopreserved grafts).
The failure rates and survival times in this study were compa-
rable with previously published data, but a clear benefit could
not be demonstrated for viable meniscal allografts.
Previous studies have shown that meniscal allografts are
more prone to failure when they are implanted into severely
degenerated or malaligned knee joints28,35,36. Nonetheless, with
the numbers available, our results did not indicate any signifi-
cant difference between failures and successful allografts with
regard to these parameters at the time of transplantation. The
preoperative pain score, however, was found to be a negative
predictor of clinical failure in the overall medial allograft
group as well as in the isolated medial allograft subgroup.
A majority of the failures was characterized by progres-
sive degeneration of the articular cartilage, and all but one was
associated with degeneration of the meniscal allograft. As we
did not evaluate the status of the articular cartilage and the me-
niscal allograft at the time of the latest follow-up of the success-
ful cases, we can conclude only that degeneration of the
articular cartilage correlates moderately with degeneration of
the meniscal allograft at the time of failure. This indicates an
intricate relationship between these two articular components.
There is still uncertainty about the best surgical fixation
technique37. Several in vitro biomechanical studies on human
cadaveric knees have shown that, for both the medial and the
lateral meniscus, bone-plug fixation provides better strength
than does soft-tissue fixation8-11. However, the authors of these
studies did not take into account the biomechanical behavior
after the allograft had healed to the meniscal rim. It had not
been documented that bone-plug fixation or soft-tissue fixa-
tion leads to longer survival or better clinical results24,25.
This study also had limitations. First, the criteria for
failure were based on clinical and arthroscopic findings. There
may have been meniscal implants that were substantially de-
generated, torn, or unstable but were asymptomatic and thus
not considered a failure. These cases could have been identi-
fied by magnetic resonance imaging, which has an established
role in the diagnosis of meniscal lesions. However, the correla-
tion between the findings of magnetic resonance imaging and
the clinical outcome is still at issue22,23,38.
A second limitation of our study was that the involved
knee joints were evaluated clinically with the modified HSS
scoring system17, which was originally designed for the evalua-
tion of patients undergoing knee joint arthroplasty. When we
started our study in 1989, no other clinical scoring system was
available for evaluating the clinical outcome of meniscal al-
lograft transplantation. Even today, meniscal allograft proce-
dures are being evaluated with a variety of scoring systems,
indicating the lack of a “gold-standard” evaluation system.
This hampers comparison with results published elsewhere.
Third, as a result of the wide variability in surgical tech-
niques, concomitant procedures, and clinical scoring systems
described in the literature, it is impossible to ascertain whether
viable meniscal allografts have more clinical benefit than do
cryopreserved or deep-frozen allografts. A controlled study
should be able to shed more light on this interesting topic.
In conclusion, this study showed that transplantation of
a viable meniscal allograft significantly reduces pain and im-
proves function of the knee joint after meniscectomy. This
beneficial effect remained in approximately 70% of the pa-
tients at ten years after the surgery. Ultimately, this study iden-
tified the need for a prospective study comparing patients
with similar symptoms and clinical findings treated with and
without a meniscal allograft and followed for a longer period
with use of clinical evaluation as well as more objective docu-
mentation tools to measure the actual fate of the allograft it-
self and the articular cartilage.
TABLE VI (continued)
Preop. Pain Score (points) Preop. Function Score (points) 
Non-Failures* Failures* P Value Non-Failures* Failures* P Value
14.4 ± 8.2 6.4 ± 5.0 0.008 62.4 ± 20.9 50.0 ± 27.9 0.34
16.0 ± 9.7 5.0 ± 7.1 0.18 61.0 ± 12.0 70.0 ± 14.2 0.36
15.0 ± 6.7 5.7 ± 5.3 0.013 66.7 ± 20.7 45.0 ± 32.4 0.23
14.9 ± 9.3 14.4 ± 10.1 0.99 61.1 ± 17.2 61.1 ± 25.3 0.96
15.4 ± 9.3 15.0 ± 10.7 0.96 60.9 ± 18.4 64.4 ± 25.0 0.67
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Appendix
Tables presenting individual patient data, the modified HSS
scoring system, and scatter plots of the failures are available
with the electronic versions of this article, on our web site at
jbjs.org (go to the article citation and click on “Supplementary
Material”) and on our quarterly CD-ROM (call our subscription
department, at 781-449-9780, to order the CD-ROM). 
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